ReviewFrontiers in pharmacology2026
Preclinical screening models in anticancer drug development: strengths, limitations, and translational challenges.
Rishikesh Yadav et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it